JP2003530071A - 細胞内シグナル伝達分子 - Google Patents
細胞内シグナル伝達分子Info
- Publication number
- JP2003530071A JP2003530071A JP2001503896A JP2001503896A JP2003530071A JP 2003530071 A JP2003530071 A JP 2003530071A JP 2001503896 A JP2001503896 A JP 2001503896A JP 2001503896 A JP2001503896 A JP 2001503896A JP 2003530071 A JP2003530071 A JP 2003530071A
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence number
- sequence
- intra
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13956699P | 1999-06-16 | 1999-06-16 | |
| US60/139,566 | 1999-06-16 | ||
| US14964099P | 1999-08-17 | 1999-08-17 | |
| US60/149,640 | 1999-08-17 | ||
| US16441799P | 1999-11-09 | 1999-11-09 | |
| US60/164,417 | 1999-11-09 | ||
| PCT/US2000/016636 WO2000077040A2 (fr) | 1999-06-16 | 2000-06-16 | Molecules de signalisation intracellulaires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2003530071A true JP2003530071A (ja) | 2003-10-14 |
Family
ID=27385364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001503896A Pending JP2003530071A (ja) | 1999-06-16 | 2000-06-16 | 細胞内シグナル伝達分子 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1203081A2 (fr) |
| JP (1) | JP2003530071A (fr) |
| AU (1) | AU5619100A (fr) |
| CA (1) | CA2374909A1 (fr) |
| WO (1) | WO2000077040A2 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3593482B2 (ja) * | 1999-11-24 | 2004-11-24 | 独立行政法人 科学技術振興機構 | WWドメインを有するヒト核蛋白質とそれをコ−ドするcDNA |
| WO2001042294A2 (fr) * | 1999-12-13 | 2001-06-14 | Arbor Vita Corporation | Proteine transmembranaire clasp-4 |
| US20040054135A1 (en) * | 2000-03-30 | 2004-03-18 | Claudia Wilm | Novel calcium - binding regulatory subunit |
| WO2003014298A2 (fr) * | 2001-08-03 | 2003-02-20 | Origene Technologies, Inc. | Polynucleotides et polypeptides selectifs pour la prostate et presentant une longueur totale de chaine |
| DE10222845A1 (de) * | 2002-05-23 | 2003-12-04 | Dresden Arzneimittel | Klonierung, Expression und Charakterisierung der Gesamtsequenz von Phosphodiesterase 8B |
| WO2004042077A2 (fr) * | 2002-11-08 | 2004-05-21 | Bayer Healthcare Ag | Diagnostics et traitements de maladies associees a la phosphodiesterase 8b humaine (pde8b) |
| US20040197770A1 (en) * | 2002-11-14 | 2004-10-07 | Mount Sinai School Of Medicine | Induction of apoptosis by HIV-1 infected monocytic cells |
| US8148320B2 (en) | 2005-12-01 | 2012-04-03 | New York Blood Center, Inc. | Peptide inhibitors of ABL kinases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3354149B2 (ja) * | 1991-04-19 | 2002-12-09 | ザ ボード オブ リージェンツ オブ ザ ユニヴァーシテイ オブ ワシントン | 哺乳類ホスホジエステラーゼをコードするdna |
| US5969101A (en) * | 1995-10-27 | 1999-10-19 | Duke University | ABL-interactor protein |
| AU5926296A (en) * | 1996-05-21 | 1997-12-09 | President And Fellows Of Harvard College | Human cis protein |
-
2000
- 2000-06-16 AU AU56191/00A patent/AU5619100A/en not_active Abandoned
- 2000-06-16 JP JP2001503896A patent/JP2003530071A/ja active Pending
- 2000-06-16 CA CA002374909A patent/CA2374909A1/fr not_active Abandoned
- 2000-06-16 EP EP00941487A patent/EP1203081A2/fr not_active Withdrawn
- 2000-06-16 WO PCT/US2000/016636 patent/WO2000077040A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000077040A3 (fr) | 2001-04-26 |
| CA2374909A1 (fr) | 2000-12-21 |
| AU5619100A (en) | 2001-01-02 |
| EP1203081A2 (fr) | 2002-05-08 |
| WO2000077040A9 (fr) | 2002-08-01 |
| WO2000077040A2 (fr) | 2000-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003527089A (ja) | 膜関連タンパク質 | |
| JP2003533967A (ja) | ヒトシンセターゼ | |
| JP2003509053A (ja) | プロテインホスファターゼ及びプロテインキナーゼ | |
| JP2003505029A (ja) | Gtp結合関連タンパク質 | |
| JP2003510024A (ja) | プロテアーゼ及びプロテアーゼインヒビター | |
| JP2004533222A (ja) | 免疫グロブリンスーパーファミリータンパク質 | |
| JP2003530071A (ja) | 細胞内シグナル伝達分子 | |
| JP2005504546A (ja) | 細胞内シグナル伝達分子 | |
| JP2005500830A (ja) | 構造および細胞骨格結合タンパク質 | |
| JP2004528805A (ja) | タンパク質ホスファターゼ | |
| JP2002543839A (ja) | ヒト組織に発現する完全長分子 | |
| CA2449272A1 (fr) | Molecules intracellulaires de signalisation | |
| JP2003527092A (ja) | 細胞分化に関与するタンパク質 | |
| JP2004529603A (ja) | アデニリルシクラーゼ及びグアニリルシクラーゼ | |
| US20030211513A1 (en) | Intracellular signaling proteins | |
| JP2004528002A (ja) | 分泌分子および輸送分子 | |
| JP2003510035A (ja) | アポトーシスタンパク質 | |
| JP2005511028A (ja) | 疾患検出および治療用分子 | |
| JP2004509610A (ja) | 核内ホルモン受容体 | |
| WO2002031152A2 (fr) | Molecules de signalisation intracellulaire | |
| JP2004519217A (ja) | 微小管関連タンパク質およびチューブリン | |
| JP2004535759A (ja) | 免疫グロブリンスーパファミリタンパク質 | |
| JP2003504060A (ja) | ヒトlimドメインタンパク質 | |
| JP2004532006A (ja) | 細胞内シグナル伝達分子 | |
| WO2004067712A2 (fr) | Molecules de signalisation intracellulaire |